Rossmax International Ltd. (TPEX:4121)
9.91
-0.89 (-8.24%)
Nov 20, 2026, 1:30 PM CST
Rossmax International Revenue
Rossmax International had revenue of 985.34M TWD in the quarter ending September 30, 2026, with 4.71% growth. This brings the company's total for the last twelve months to 3.82B, up 0.08% year-over-year. In the year 2025, Rossmax International had annual revenue of 3.80B, down -1.34%. That makes Rossmax International the 21,626th largest company in the world by revenue and 874th in Taiwan.
Revenue (ttm)
3.82B
Revenue Growth
+0.08%
P/S Ratio
0.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
820.03M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Rossmax International breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.80B | -51.80M | -1.34% |
| Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
| Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
| Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
| Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 2.95B |
| AViTA | 1.05B |
| Bioptik Technology Incorporation | 891.73M |
| Diamond Biotechnology | 464.63M |
| Radiant Innovation | 417.97M |
| Wiltrom | 314.12M |
| S&S Healthcare Holding | 185.52M |
| Taiwan Biomaterial | 153.37M |